| 书目名称 | Cancer Therapeutics | | 副标题 | Experimental and Cli | | 编辑 | Beverly A. Teicher | | 视频video | http://file.papertrans.cn/222/221212/221212.mp4 | | 丛书名称 | Cancer Drug Discovery and Development | | 图书封面 |  | | 描述 | Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of | | 出版日期 | Book 1997 | | 关键词 | DNA; angiogenesis; cancer; cancer treatment; cytokine; cytokines; drug; drug development; drug discovery; gen | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-59259-717-8 | | isbn_softcover | 978-1-61737-046-5 | | isbn_ebook | 978-1-59259-717-8Series ISSN 2196-9906 Series E-ISSN 2196-9914 | | issn_series | 2196-9906 | | copyright | Springer Science+Business Media New York 1997 |
The information of publication is updating
|
|
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-7-12 06:51
发表于 2025-3-21 17:49:27
